Michigan early stage venture firm Arboretum adds former Aastrom Biosciences CEO
Early stage health investor Arboretum Ventures has added George Dunbar, former chief executive of Michigan biotech company Aastrom Biosciences Inc., as a partner.
Michigan’s Accuri Cytometers raises $4 million
The company said it needed to raise the money to keep up with demand. Accuri launched its Accuri C6 Flow Cytometer in April 2008 and followed that launch three months later with a $13 million raise to expand its marketing and sales efforts of the product.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
CerviLenz closes on $4 million Series A round to create preterm pregnancy detector
The company is developing a disposable device that measures the length of a woman's cervix to help predict risks of preterm birth. It is potentially easier, less costly and just as accurate as the transvaginal ultrasound device used in only high-risk pregnancies. It could be in the market by 2010.
Are venture capitalists ready to resume biomedical investing?
Biomedical companies with compelling technologies could win millions of dollars in investments this year despite the worst gloom in financial markets since the Great Depression.